ENTITY

Abeona Therapeutics (ABEO US)

4
Analysis
Health CareUnited States
Abeona Therapeutics Inc. is a leading clinical-stage biopharmaceutical company. The Company develops novel gene therapies for life-threatening rare diseases.
more
20 Nov 2024 01:00Issuer-paid

ABEO: FDA Accepts BLA Re-Submission for Pz-cel PDUFA Date of April 29

On November 14, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the third quarter of 2024 and provided a business...

Share
15 Aug 2024 05:00Issuer-paid

ABEO: Type A Meeting with FDA Concluded BLA Submission on Track for 2H24

On August 12, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the second quarter of 2024 and provided a business...

Share
29 May 2024 00:00Issuer-paid

ABEO: BLA Resubmission in 2H24

On May 15, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2024 and provided a business update. The...

Share
x